Uthever® Supplementation Proved to Mitigate Radiotherapy-induced Damages

      Radiotherapy is one of the main treatment options for many different types of cancers as it has a high success rate in destroying cancerous cells. However, there is no existing way to prevent the inevitable harm caused by the ionizing radiations on neighbouring healthy cells and tissues.

      60-80% of patients undergoing radiotherapy for abdominal or pelvic cancers displayed radiation-induced intestinal damage among other complications.1​ Nicotinamide mononucleotide (NMN), the precursor of NAD+ (Nicotinamide Adenine Dinucleotide), has been shown to bring many benefits to its users and NMN supplementation is shown to relieve the aforementioned damage and complications caused by radiotherapy.


      Radiation induced intestinal damage and complications

      The intestinal tract is notable for the fast renewal and proliferation of its cells, which results in the organ’s increased receptivity to stimulation from the environment. Patients who undergo radiotherapy for the treatment of abdominal and pelvic tumours are at an increased risk of developing early intestinal injury manifestations such as abdominal distention, abdominal pain, nausea, loss of appetite, and acute diarrhoea.2​ These symptoms have significant negative impact on the patient’s quality of life. Additionally, older adults usually have an altered intestinal structure, decreased regenerative and proliferative ability, and other aspects, all of which could make their intestines more susceptible to ionized-radiation treatments.1,3

      Chronic intestinal deterioration, a significant unfavourable consequence in long-term cancer survivors, typically occurs anywhere from a few months to three years after radiotherapy treatments and can result in microvascular sclerosis, intestinal fibrosis, and mucosal atrophy. This type of damage to the intestines can be life-threatening.2


      1. Radiation Induced Intestinal Damages Mitigated by Modulating Gut Microbiota

      A link between gut microbiota and radiation induced intestinal injury

      Recent studies have shown that there is an irrefutable link between the gut microbiota and radiation-induced intestinal damage.1,3,4​ These studies have demonstrated that radiation alters the gut microbiome in relation to its number and diversity. These alterations have affected the gastrointestinal system resulting in complications such as diarrhoea and enteritis.

      Studies have indicated that ionising radiation (IR) has lead to a reduction in beneficial bacteria and an increment of harmful bacteria. It is suggested that this leads to higher intestinal sensitivity to inflammation, predisposing the gut mucosa to radiation-induced damage. The microbiota of the gut is closely related to side effects of radiotherapy.1

      Furthermore, studies have shown that mice who were pre-treated with antibiotics (germ-free) were less affected from radiation therapy, insinuating that there is an undeniable relationship between gut microbiome and radiation-induced intestinal damages (Crawford and Gordon 2005; Zhao et al​. 2022). 1,7​ In addition, evidence suggests that treatment with probiotics and transplantation of microbiota from healthy mice to mice exposed to long-term radiation has alleviated radiation-induced acute intestinal injury.1

      Uthever® NMN modulates gut microbiota and intestinal fibrosis 

      A study sponsored by Uthever® found that supplementation of Uthever® NMN reshaped the composition of gut microbiota and alleviated intestinal fibrosis caused by abdominal and pelvic cancer radiotherapy.1​ Mice were employed in the study and were irradiated in the abdomen and then given NMN supplements. After irradiation, faeces were collected and 16S rRNA sequencing was done to identify the gastrointestinal tract microbiota.

      It was found that supplementation of Uthever® NMN over a long period changed the composition and function of gut microbiota that had been disrupted by ionizing radiation (IR). NMN treatment resulted in increased abundance of beneficial bacteria and inhibited the proliferation of harmful bacteria.1​ “The alterations in the composition of the gut microbiota eventually contribute to the changes in its functions, including cellular processes, metabolism, and human diseases,” Zhao et al​. stated.1

      The same study also detected the collagen deposition in colonic tissues using Masson’s trichrome staining (collagen stained in blue) and showed that ionizing radiation (IR) significantly increased collagen deposition leading to intestinal fibrosis. The study also demonstrated how NMN supplementation inhibited this process leading to reduced fibrosis.

      Picture1 - C Zhao et al

      Above:​ The Masson staining’s representative pictures (Source: Zhao et al., 2022)1​ ​​

      Picture 2 D Zhao et al histogram

      Above: A histogram displaying the intensity of the Masson stain (Source: Zhao et al., 2022)1​ ​​

      As there is an intimate relationship between the gut microbiota and radiation-induced intestinal injury, the alterations in microbiota brought about by Uthever® NMN were able to successfully counteract the effects of radiotherapy and help in preservation of beneficial effects of the gut microbiota, and thereby reduce the risks and relieve harmful effects of IR induced intestinal injury (Zhao et al​. 2022).1


      2. NRF2: ​Reducing Radiation-Induced Intestinal Damages by Strengthening Antioxidant and DNA Repair Mechanisms

      Radiation and DNA damage: Role of NRF2

      The principle behind radiotherapy for cancer cells is the destruction of cancer cells using ionizing radiation (IR). IR can induce production of Reactive Oxygen Species (ROS) or act directly on the genome to induce DNA damage in cancer cells. Ionizing radiation induces radiolysis of molecules of water, which results in the production of a number of free ions, electrons, and radicals, including the hydroxyl radical (-OH), increasing oxidative stress and further provoking DNA damage.5,6​ These radiations can also damage neighbouring normal cells and tissues as well. As for abdominal and pelvic cancer radiotherapy, IR usually promotes intestinal injury and causes adverse effects. Elderly populations are affected more severely as their antioxidant and DNA repair systems weaken with aging.

      A transcription factor called nuclear factor erythroid-2-related factor 2 (NRF2) binds to the antioxidant response element (ARE) in DNA and regulates expression of genes involved in DNA repair and antioxidant systems. Therefore, NRF2 inducers have been used as powerful antioxidant therapeutic drug in order to cure ailments that are brought on by radiotherapy of cancerous tissues/cells.8,9

      Sirtuins are a class of proteins which are known to be closely associated with aging and longevity. They also involved in supporting antioxidant and DNA repair systems. For example, SIRT1, SIRT6 and SIRT7 are the three members of Sirtuin family found in the nucleus, which might be able to regulate the expression of antioxidant genes by interacting with NRF2. SIRT1, SIRT6, and SIRT7 have been found to have a role during DNA damage response.

      Uthever® NMN helps elevate NRF2

      Another study sponsored by Uthever® found a promising solution for alleviating IR-induced damages by elevating the NRF2 levels with the help of NMN supplementation. NMN has an agonistic effect on NRF2. The study which was conducted on mice to evaluate the effects of Uthever® NMN on alleviating intestinal injuries caused by radiotherapy of cancer treatments, found that lowering or silencing the level of NRF2 enhances reactive oxygen species (ROS) levels and makes body tissues more vulnerable to radiation, which ultimately increases the severity of IR-induced side effects (Zhao et al., 2022).6​ Furthermore, it was proven that Uthever® NMN administration, could reverse the damages and offer a shielding effect by repairing DNA damage and alleviating intestine injury caused by cancer radiotherapy.

      Some of NAD+ dependent sirtuins family members (SIRT1-7 i.e. SIRT1, 2, 3, etc) that involve in longevity also act alongside NRF2. ​NMN also have a synergistic effect on these proteins. Uthever® NMN administration was found to have enhanced the effects on these proteins as well (Zhao et al., 2022).6​ It was found that the excess of SIRT7 and SIRT6, as well as the NMN administration, could reverse the damages and offer a shielding effect by repairing DNA damage and alleviating intestine injury caused by cancer radiotherapy.

      Picture3 Zhao et al 2022

      Above: NMN attenuated IR-reduced NDA damage and intestine injury ​(Source Zhao et al., 2022)6

      SIRT6/SIRT7 expression by NMN supplementation reduced IR-induced DNA damage and intestinal injury in the aged NRF2 deficient animal.

      In conclusion, studies have shown that NMN supplementation could succeed in counteracting the negative impact of radiotherapy and thereby enhance its potential as a viable and effective treatment for cancer. Clinical studies are called for to further verify that the same benefits of NMN supplementation applies to human cancer patients.

      NMN may very well be the key to unlock many of the present-day health related advancements. Its approach in relation to other spheres of health such as skin treatment, anti-aging effects and infections, will be the focus of future scientific studies.





      1.​ Zhao, X.; Ji, K., Zhang, M.; Huang, H.; et al (2022). NMN alleviates radiation-induced intestinal fibrosis by modulating gut microbiota. International Journal of Radiation Biology, 1-12.
      2.​ Hauer-Jensen, M., Denham, J. W., & Andreyev, H. J. N. (2014). Radiation enteropathy—pathogenesis, treatment and prevention. Nature reviews Gastroenterology & hepatology, 11(8), 470-479.
      3.​ Martin, K., Potten, C. S., Roberts, S. A., & Kirkwood, T. B. (1998). Altered stem cell regeneration in irradiated intestinal crypts of senescent mice. Journal of cell science, 111(16), 2297-2303.
      4.​ Nam YD, Kim HJ, Seo JG, Kang SW, Bae JW. 2013. Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing. PLoS One. 8(12):e82659
      5.​ Bai, J., Barandouzi, Z. A., Rowcliffe, C., Meador, R., Tsementzi, D., & Bruner, D. W. (2021). Gut microbiome and its associations with acute and chronic gastrointestinal toxicities in cancer patients with pelvic radiation therapy: a systematic review. Frontiers in oncology, 11, 5237.
      6​. Zhao, X., Zhang, M., Wang, J., Ji, K., Wang, Y., Sun, X., & Liu, Q. (2022). NMN ameliorated radiation induced damage in NRF2-deficient cell and mice via regulating SIRT6 and SIRT7. Free Radical Biology and Medicine, 193, 342-353.
      7​. Crawford PA, Gordon JI. 2005. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci U S A. 102(37):13254–13259
      8​. Wei, J. et al. (2021) “Sulforaphane-mediated Nrf2 activation prevents radiation-induced skin injury through inhibiting the oxidative-stress-activated DNA damage and NLRP3 inflammasome,” Antioxidants (Basel, Switzerland), 10(11), p. 1850. doi: 10.3390/antiox10111850.
      9​. Nakagami, Y. (2017) “Nrf2 activators as therapy for acute radiation dermatitis,” Journal of Rare Diseases Research & Treatment, 2(3), pp. 11–15. Doi: 10.29245/2572-9411/2017/3.1109.

  • Subacute Toxicity of NMN

    The administration of Nicotinamide mononucleotide(NMN) which is a key precursory metabolite of NAD+ has been reported to have remarkable therapeutic effects on age-related diseases. However systemic evaluation pertaining to the subacute toxicity of NMN remains to be determined.   Recently,...
  • Hi Mrs, NMN Helps Pregnancy

    With the increasing, late marriage and late childbirth in China, as well as the two-child policy, and even the looming phenomenon of the third child in some regions, the group of elderly pregnant women has begun to approach the public's...
  • NMN, A Heart Disease Terminator

    As the engine of the human body, the heart occupies an incomparable position in the body. Obligations, however, go hand in hand with responsibilities. The fate of the heart is from birth to work to death, but why is the...
  • What are the changes NMN can visibly make on you?

    Since the nicotinamide mononucleotide (NMN) was found to promote the increase of NAD+ in the body, the scientific research on its anti-aging effect in an endless stream of studies, and some even dubbed it a "longevity drug". However, whether NMN...
  • NMN Has Anti-Aging Potential for Kidneys

    The world’s population of older adults continues to expand at an unprecedented pace. So, there is a need for a better understanding of aging processes to mitigate age-related diseases and disorders. But not all organs age at the same pace,...
  • How does NMN work in Sirtfood Diet?

    It’s common knowledge that health and longevity go hand in hand with diet, which has encouraged many people to pay close attention to what they eat. Although restricting calorie intake and fasting are proven methods to promote weight loss and...
  • Meet us at CPhi 2020 at E5A08

    From 16Dec to 18Dec 2020, Effepharm will attend CPhi 2020 in Shanghai, China. As an exhibitor, our booth will be E5A08 At the expo, Effepharm will introduce its next-generation NMN - Uthever® to our customers and the public. Looking forward...
  • UTHEVER®NMN awarded 2020 Top 10 Hot raw materials in the nutrition and health industry

    2020 Nutrition Health Entrepreneur Conference (NHEC) was hosted in Bejing International Conference center on Nov.22nd, 2020. With the theme of "Embracing the Future of change and Win-win," this annual conference brings together leaders from national ministries and commissions, authoritative experts...
  • Effepharm Won the 2020 “NEW POWER” Innovation Award For the NMN Brand Material UTHEVER®

    Asiaceutical Summit & Expo 2020 took place in Guangzhou from October 21st to 23rd. This conference was hosted by the Herbridge, which gathered the experts in foods, beverage and health care industry. Experts provided cutting edge perspectives under the circumstances of...
  • Meet us at Asiaceutical Summit & Expo 2020

    From 21Oct to 23Oct 2020, Effepharm will attend Asiaceutical Summit & Expo 2020 in Guangdong, China. As an exhibitor, our booth will be B17. At the expo, Effepharm will introduce its next-generation NMN - Uthever® to our customers and the...
  • Clinical evidence on the safety of NMN released recently

    Researchers from Keio University and Washington University published a new article on Endocrine Journal. The safety of single dose at 100, 250, and 500 mg NMN was investigated in 10 Japanese men. Clinical findings and parameters, and the pharmacokinetics of NMN metabolites were...
  • Effepharm started new clinical trials on Uthever™ as

    Effepharm started our new clinical trials on UtheverTM NMN ingredient recently. According to ICTRP ( International Clinical Trials Registry Platform),  the clinical trial on UtheverTM is the largest scale trial on NMN in the world. What’s more, Effepham is the first and the...
  • Effepharm announced acquisitions and new R&D center establishment

    Effepharm acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has significantly enhanced our R&D capability in anti-aging and energy metabolism. Also Effepharm’s new R&D center is established. Effepharm’s new R&D center will focus on new pharmaceutical...
  • Effepharm team at ”Hi Japan”

      From 2nd to 4th Oct 2019, Effepharm team participated in Hi Japan Exhibit, the Largest Trade Show for Functional & Health Ingredients in Japan. Effepharm is in line with the purpose of this event. Its Highlights: not only the food...
  • Effepharm team in the Vitafoods Europe 2019

    On 7th May, 2019, Sales team at Effepharm came to vitafoods with latest products and new technology. Booth Position:Sliver Area  No. N189 NMN- Popular NAD+ Precursors CBD- This ingredient is very popular in many Europe countries. Effepharm’s R&D has scheduled...
  • New Laboratory has been completed!

    Effepharm Ltd. currently not only holds a strong R&D team consisting of experienced  PHDs and Postdocs returned from abroad, but also employs senior professors and  scholars at home and abroad as a team of research consultants to help us optimize ...
  • Meet Us at the Vitafoods Europe 2019!

      May. 2019, Effepharm teams will participate in Vitafoods Europe 2019 Exhibit, a annual event where the global  nutraceutical supply chain come to gether to do business At that time, Effepharm teams will be waiting for your inquiry and cooperation...
  • “Once-in-two-lifetimes Ingredients”–NMN or NR?

    “Once-in-two-lifetimes Ingredients”--NMN or NR? Nowadays, the people all over the world spend billions of dollars on anti-aging products. While most anti-aging products try to reverse signs of aging on your skin, Nicotinamide Rboside aims to reverse signs of aging from inside your...
  • Sales Office transferred to Shanghai

    Sales Office transferred to Shanghai The sales office was transferred to Shanghai in 2017-EffePharm(Shanghai)Co.,Ltd At Effepharm, we apply science and technologies to improve health and well-being at every stage of life with innovative thinking. Our dedicated team strive to set...